ANIK
HEALTHCAREAnika Therapeutics Inc
$15.12+0.17 (+1.14%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ANIK Today?
No stock-specific AI insight has been generated for ANIK yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$7.87$16.24
$15.12
Fundamentals
Market Cap$201M
P/E Ratio—
EPS$-0.79
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume110K
Avg Volume (10D)—
Shares Outstanding13.3M
ANIK News
20 articles- President of Anika Therapeutics Picks Up 51% More StockYahoo Finance·May 3, 2026
- TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 RevenuesYahoo Finance·Apr 30, 2026
- Anika Therapeutics, Inc. Q1 2026 Earnings Call SummaryMoby·Apr 29, 2026
- Anika Therapeutics Q1 Earnings Call HighlightsMarketbeat·Apr 29, 2026
- Anika Reports First Quarter 2026 Financial ResultsYahoo Finance·Apr 29, 2026
- Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of DirectorsYahoo Finance·Apr 16, 2026
- Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026Yahoo Finance·Apr 15, 2026
- Telix Strengthens Board with Additional Director AppointmentsYahoo Finance·Apr 8, 2026
- Revance CEO Nadeem Moiz on Expansion, Opportunities & CapitalizationYahoo Finance·Apr 7, 2026
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·Apr 3, 2026
- Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK ConferenceMarketbeat·Mar 3, 2026
- Anika Therapeutics, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 27, 2026
- Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Highlights: Strong International Growth and ...Yahoo Finance·Feb 26, 2026
- Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat EstimatesYahoo Finance·Feb 26, 2026
- Anika Therapeutics Q4 Earnings Call HighlightsMarketbeat·Feb 26, 2026
- Anika: Q4 Earnings SnapshotYahoo Finance·Feb 26, 2026
- Anika Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Feb 26, 2026
- Anika To Present at the Canaccord Genuity 2026 Musculoskeletal ConferenceYahoo Finance·Feb 18, 2026
- Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026Yahoo Finance·Feb 12, 2026
- Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of DirectorsYahoo Finance·Feb 4, 2026
All 20 articles loaded
Price Data
Open$14.57
Previous Close$14.95
Day High$15.18
Day Low$14.57
52 Week High$16.24
52 Week Low$7.87
52-Week Range
$7.87$16.24
$15.12
Fundamentals
Market Cap$201M
P/E Ratio—
EPS$-0.79
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume110K
Avg Volume (10D)—
Shares Outstanding13.3M
About Anika Therapeutics Inc
Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally. The company is headquartered in Bedford, Massachusetts.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—